Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis.
Sphingosine 1-phosphate (S1P): Physiology and the effects of S1P receptor modulation.
Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis.
Heat shock protein 27 in multiple sclerosis relapses.
Added benefit of fampridine is not proven
Contributions of vitamin D response elements and HLA promoters to multiple sclerosis risk.
Quantitative proton density mapping: correcting the receiver sensitivity bias via pseudo proton densities.
Subclinical CNS Inflammation as Response to a Myelin Antigen in Humanized Mice.
Severe septal panniculitis in a multiple sclerosis patient treated with interferon-beta.
Effects of functional electrical stimulation on gait function and quality of life for people with multiple sclerosis taking dalfampridine.
A Novel MicroRNA-132-Surtuin-1 Axis Underlies Aberrant B-cell Cytokine Regulation in Patients with Relapsing-Remitting Multiple Sclerosis.
At Four Years, Treatment Effect Maintained in More Than Two-Thirds of Patients Who Received Genzyme’s Lemtrada in Pivotal Studies
Posterior brain damage and cognitive impairment in pediatric multiple sclerosis.
[Side-effects of glucocorticosteroids in multiple sclerosis: a case report of a patient with global amnesia.]
Gray matter is targeted in first-attack multiple sclerosis.
Transplantation of umbilical cord and bone marrow-derived mesenchymal stem cells in a patient with relapsing-remitting multiple sclerosis.
Multiple sclerosis: summary of NICE guidance.
Re-engineering of pathogenic aquaporin 4-specific antibodies as molecular decoys to treat neuromyelitis optica.
Increase in the prevalence of multiple sclerosis over a 17-year period in Osona, Catalonia, Spain.
Including known covariates can reduce power to detect genetic effects in case-control studies.
Potential Role of Glucagon-Like Peptide-1 (GLP-1) in Neuroprotection.
Fingolimod (FTY720) inhibits neuroinflammation and attenuates spontaneous convulsions in lithium-pilocarpine induced status epilepticus in rat model.
Alemtuzumab for multiple sclerosis: Long term follow-up in a multi-centre cohort.
The safety of exercise training in multiple sclerosis: A systematic review.
Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination.

Pages